CCL2 in chronic lymphocytic leukemia: a macro in microenvironment?
作者信息
Gandhi Varsha, Balakrishnan Kumudha
机构信息
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA.
出版信息
Leuk Lymphoma. 2012 Oct;53(10):1849-50. doi: 10.3109/10428194.2012.688966. Epub 2012 May 21.
Abstract
摘要
相似文献
1
CCL2 in chronic lymphocytic leukemia: a macro in microenvironment?慢性淋巴细胞白血病中的CCL2：微环境中的一个“大角色”？
Leuk Lymphoma. 2012 Oct;53(10):1849-50. doi: 10.3109/10428194.2012.688966. Epub 2012 May 21.
2
CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro.CCL2 和 CXCL2 增强体外原发性慢性淋巴细胞白血病细胞的存活。
Leuk Lymphoma. 2012 Oct;53(10):1988-98. doi: 10.3109/10428194.2012.672735. Epub 2012 Apr 19.
3
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.炎症细胞因子和信号通路与原发性慢性淋巴细胞白血病细胞体外存活有关：CCL2 起主要作用。
Haematologica. 2011 Mar;96(3):408-16. doi: 10.3324/haematol.2010.031377. Epub 2010 Dec 6.
4
The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat.大鼠创伤性脑损伤后趋化因子MIP-2和MCP-1的时间表达、细胞定位及抑制情况
J Neurotrauma. 2009 Apr;26(4):507-25. doi: 10.1089/neu.2008.0686.
5
Induction of CXCL2 and CCL2 by pressure force requires IL-1β-MyD88 axis in osteoblasts.压力诱导CXCL2和CCL2生成需要成骨细胞中的IL-1β-MyD88轴。
Bone. 2015 May;74:76-82. doi: 10.1016/j.bone.2015.01.007. Epub 2015 Jan 17.
6
Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains.趋化因子 CXCL1、CXCL2 和 CCL2 与小鼠肾小球内皮细胞的差异结合揭示了对不同肝素硫酸酯域的特异性。
PLoS One. 2018 Sep 24;13(9):e0201560. doi: 10.1371/journal.pone.0201560. eCollection 2018.
7
Therapeutic action against chronic cholestatic liver injury by low-dose fenofibrate involves anti-chemotaxis via JNK-AP1-CCL2/CXCL2 signaling.低剂量非诺贝特通过 JNK-AP1-CCL2/CXCL2 信号通路发挥抗慢性胆汁淤积性肝损伤的治疗作用。
Pharmacol Rep. 2020 Aug;72(4):935-944. doi: 10.1007/s43440-019-00043-8. Epub 2020 Jan 8.
8
AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.AMD3100 破坏慢性淋巴细胞白血病细胞与间充质基质或类滋养细胞为基础的微环境之间的串扰：与慢性淋巴细胞白血病治疗相关的临床前证据。
Haematologica. 2012 Apr;97(4):608-15. doi: 10.3324/haematol.2011.052779. Epub 2011 Nov 4.
9
Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.在患有乳腺癌的小鼠的 T 淋巴细胞中表达炎症趋化因子 CCL2、CCL5 和 CXCL2 及其受体 CCR1-3 和 CXCR2。
Cell Immunol. 2011;270(2):172-82. doi: 10.1016/j.cellimm.2011.05.004. Epub 2011 May 10.
10
Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium.趋化因子转录本作为人类气道上皮细胞中RNA结合蛋白HuR的作用靶点
J Immunol. 2011 Feb 15;186(4):2482-94. doi: 10.4049/jimmunol.0903634. Epub 2011 Jan 10.
引用本文的文献
1
Tumor Cell Survival Factors and Angiogenesis in Chronic Lymphocytic Leukemia: How Hot Is the Link?慢性淋巴细胞白血病中的肿瘤细胞存活因子与血管生成：二者关联有多紧密？
Cancers (Basel). 2024 Dec 29;17(1):72. doi: 10.3390/cancers17010072.
2
The Yin-Yang of myeloid cells in the leukemic microenvironment: Immunological role and clinical implications.白血病微环境中髓系细胞的阴阳两面：免疫作用及临床意义。
Front Immunol. 2022 Dec 1;13:1071188. doi: 10.3389/fimmu.2022.1071188. eCollection 2022.
3
Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells.慢性淋巴细胞白血病中的巨噬细胞极化：类护士细胞是白血病细胞的守护者。
Biomedicines. 2020 Nov 19;8(11):516. doi: 10.3390/biomedicines8110516.
4
Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC.体外miR-532-5p缺失通过影响肝癌中CXCL2的表达促进细胞增殖和转移。
Am J Transl Res. 2015 Nov 15;7(11):2254-61. eCollection 2015.
本文引用的文献
1
CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro.CCL2 和 CXCL2 增强体外原发性慢性淋巴细胞白血病细胞的存活。
Leuk Lymphoma. 2012 Oct;53(10):1988-98. doi: 10.3109/10428194.2012.672735. Epub 2012 Apr 19.
2
Hallmarks of cancer: the next generation.癌症的特征：下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
3
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.炎症细胞因子和信号通路与原发性慢性淋巴细胞白血病细胞体外存活有关：CCL2 起主要作用。
Haematologica. 2011 Mar;96(3):408-16. doi: 10.3324/haematol.2010.031377. Epub 2010 Dec 6.
4
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.CCL3（MIP-1α）血浆水平与慢性淋巴细胞白血病疾病进展的风险。
Blood. 2011 Feb 3;117(5):1662-9. doi: 10.1182/blood-2010-09-307249. Epub 2010 Nov 29.
5
Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells.关于 AMD3100（一种 SDF-1/CXCL12-CXCR4 抑制剂）在动员造血干细胞和祖细胞方面的临床经验更新。
Curr Opin Hematol. 2010 Jul;17(4):319-26. doi: 10.1097/MOH.0b013e328338b7d5.
6
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.多种骨髓基质细胞可保护慢性淋巴细胞白血病细胞免受自发凋亡和药物诱导的凋亡：建立一个可靠且可重复的系统来评估基质细胞黏附介导的耐药性。
Blood. 2009 Nov 12;114(20):4441-50. doi: 10.1182/blood-2009-07-233718. Epub 2009 Sep 17.
7
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.慢性淋巴细胞白血病B细胞在类滋养细胞共培养中以及BCR刺激后对T细胞趋化因子CCL3和CCL4的高水平表达。
Blood. 2009 Mar 26;113(13):3050-8. doi: 10.1182/blood-2008-07-170415. Epub 2008 Dec 12.
8
CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation.趋化因子配体2通过磷脂酰肌醇3激酶/蛋白激酶B依赖性生存素上调保护前列腺癌PC3细胞免于自噬性死亡。
J Biol Chem. 2008 Sep 5;283(36):25057-73. doi: 10.1074/jbc.M801073200. Epub 2008 Jul 8.
9
10
The many roles of chemokines and chemokine receptors in inflammation.趋化因子和趋化因子受体在炎症中的多种作用。
N Engl J Med. 2006 Feb 9;354(6):610-21. doi: 10.1056/NEJMra052723.
Zotero 插件